Product List By Category

 


Pharmaceutical Ingredients

Impurities

Intermediates

Metabolites

Pheromone Ingredients



PRX001: Paroxetine [CAS # 61869-08-7]
PRX002: Paroxetine HCl [CAS # 78246-49-8]
PRX003: Paroxetine HCl Hemihydrate [CAS # 110429-35-1]
PRX004: Paroxetine Formate
PRX005: Paroxetine Acetate
PRX006: Paroxetine Sulphate
PRX007: Paroxetine Phosphate
PRX008: Paroxetine Maleate


PRX009: 4-Methoxy Paroxetine Hydrochloride; trans-4-(p-methoxyphenyl)-3-[(3,4-methylenedioxy)phenoxy]methylpiperidine hydrochloride (USP Related Compound A = EP Impurity B)


PRX010: Desfluoro Paroxetine Hydrochloride; trans-4-phenyl-3-[(3,4-methylenedioxy)phenoxy]methylpiperidine hydrochloride ("EP Impurity A")


PRX011: trans-4-phenyl-3-[(3,4-methylenedioxy)phenoxy]methylpiperidine acetate ("USP Related Compound B")


PRX012: 4-Ethoxy Paroxetine Hydrochloride ("EP Impurity C")


PRX013: (+)-trans-paroxetine hydrochloride ("USP Related Compound C" = "EP Impurity D")


PRX014: cis-paroxetine hydrochloride ("USP Related Compound D" = "EP Impurity E")


PRX015: 4-(4-Fluorophenyl)-1-methyl-1,2,3,6-tetrahydro pyridine ("USP Related Compound E" = "EP Impurity G")

   
PRX016: (3S,4R)-trans (-)-1-methyl-3-[1,3-benzodioxol-5-yloxy)methyl]-4-(fluorophenyl)piperidine ("N-Methyl Paroxetine", "NMP", "USP Related Compound F") [CAS # 110429-36-2]

   
PRX017: trans (+)-1-methyl-3-[1,3-benzodioxol-5-yloxy)methyl]-4-(fluorophenyl)piperidine


PRX018: (±)-Trans-3-ethoxycarbonyl-4-(4-fluoro phenyl)-1-methylpiperidin-2,6-dione


PRX019: (±)-Trans-4-(4-fluorophenyl)-3-hydroxymethyl-1-methylpiperidine


PRX020: (3S,4R)-Trans-(-)-4-(4-fluorophenyl)-3-hydroxymethyl-1-methylpiperidine [CAS # 105812-81-5]


PRX021: (+)-Trans-4-(4-fluorophenyl)-3-hydroxymethyl-1-methylpiperidine


PRX022: (3S,4R)-4-(4-fluorophenyl)-3-(4-hydroxy-3-methoxyphenoxymethyl) piperidine ("HM Paroxetine")


PRX023: (+)-cis-4-(4-fluorophenyl)-3-hydroxymethyl-1-methylpiperidine


PRX024: (-)-cis-4-(4-fluorophenyl)-3-hydroxymethyl-1-methylpiperidine [CAS # 153779-91-0]


PRX025: cis (±)-1-methyl-3-[1,3-benzodioxol-5-yloxy)methyl]-4-(fluorophenyl)piperidine



Patented products are only available for R&D use as permitted under CFR 35 Section 271(e)(1).

Copyright  © 2005  All Rights Reserved.

MOLCAN CORPORATION, Canada, Tel. 905-731-5537, Fax 905-248-3843, E-Mail: info@molcan.com